加载中
NASDAQHealthcareDrug Manufacturers - Specialty & Generic
最新数据
US$73.59
−US$0.30 · -0.41%
ANI Pharmaceuticals, Inc., a biopharmaceutical company, develops, manufactures, and markets branded and generic pharmaceutical products in the United States and internationally. The company provides injectables, softgel capsules, and Cortrophin gel, as well as ILUVIEN and YUTIQ products. It also manufactures oral solid dose products, semi-solids, liquids, topicals, controlled substances, and potent products. The company serves its products to national wholesalers, specialty pharmacies, retail pharmacy chains, distributors, mail order houses, group purchasing organizations, and hospitals and healthcare providers. ANI Pharmaceuticals, Inc. was incorporated in 2001 and is headquartered in Baudette, Minnesota.
前收盘价
US$73.59
−US$0.30 · -0.41%
盘后
US$73.59
US$0.00 · 0.00%
10月12日 19:30 ET
盘中时间采用ET。市场数据可能有所延迟。
ANI Pharmaceuticals, Inc., a biopharmaceutical company, develops, manufactures, and markets branded and generic pharmaceutical products in the United States and internationally. The company provides injectables, softgel capsules, and Cortrophin gel, as well as ILUVIEN and YUTIQ products. It also manufactures oral solid dose products, semi-solids, liquids, topicals, controlled substances, and potent products. The company serves its products to national wholesalers, specialty pharmacies, retail pharmacy chains, distributors, mail order houses, group purchasing organizations, and hospitals and healthcare providers. ANI Pharmaceuticals, Inc. was incorporated in 2001 and is headquartered in Baudette, Minnesota.
日内区间
当前US$73.59
52周区间
当前US$73.59
盘中时间采用ET。市场数据可能有所延迟。
GoAI 评分
买入
估值
95
深度低估
情绪
49
多空交织
风险
29
中等风险
动量
46
中性
完整 GoAI 研究
继续查看更深入的依据、催化因素和风险。
ANI Pharmaceuticals, Inc., a biopharmaceutical company, develops, manufactures, and markets branded and generic pharmaceutical products in the United States and internationally. The company provides injectables, softgel capsules, and Cortrophin gel, as well as ILUVIEN and YUTIQ products. It also manufactures oral solid dose products, semi-solids, liquids, topicals, controlled substances, and potent products. The company serves its products to national wholesalers, specialty pharmacies, retail pharmacy chains, distributors, mail order houses, group purchasing organizations, and hospitals and healthcare providers. ANI Pharmaceuticals, Inc. was incorporated in 2001 and is headquartered in Baudette, Minnesota.
日内区间
当前US$73.59
52周区间
当前US$73.59
盈利能力占已公布营收的百分比。
营收
营业利润
净利润
| 项目（USD） | 2025财年 | 2024财年 | 2023财年 | 2022财年 | 2021财年 |
|---|---|---|---|---|---|
| 营收 | 8.83亿 USD | 6.14亿 USD | 4.87亿 USD | 3.16亿 USD | 2.16亿 USD |
| 销货成本 | 4.33亿 USD | 2.5亿 USD | 1.82亿 USD | 1.39亿 USD | 1.01亿 USD |
| 毛利 | 4.51亿 USD | 3.64亿 USD | 3.05亿 USD | 1.78亿 USD | 1.16亿 USD |
| 研究与开发 | 5166.4万 USD | 4458.1万 USD | 3428.6万 USD | 2231.8万 USD | 1136.9万 USD |
| 销售、一般及管理费用 | 3.18亿 USD | 2.5亿 USD | 1.62亿 USD | 1.24亿 USD | 8429.4万 USD |
| 营业费用 | 3.69亿 USD | 3.64亿 USD | 2.58亿 USD | 2.13亿 USD | 1.55亿 USD |
| 利息支出 | 2006万 USD | 1760.2万 USD | 2694万 USD | 2805.2万 USD | 1192.2万 USD |
| 折旧和摊销 | 9141.7万 USD | 6773.1万 USD | 5979.1万 USD | 5965.3万 USD | 4725.2万 USD |
| 营业利润 | 8123万 USD | 58.4万 USD | 4697.1万 USD | −3528.3万 USD | −3979.3万 USD |
| 净利润 | 7833.7万 USD | −1852.2万 USD | 1877.9万 USD | −4789.6万 USD | −4260.3万 USD |
公司数据更新于 2026年10月13日。
已公布业绩及可用的市场共识预期。
已公布业绩及可用的市场共识预期。
第三方分析师预期可能变化，并非 GoAI 建议。
AI 生成内容及延迟市场数据仅供信息与教育用途，不构成投资建议。
